Summary
Are you looking for a basic introduction to health economic analyses with special attention to the use of QALY (Quality-adjusted Life Years) as a cost effectiveness measure? This one day course provides you with a theoretical framework and real use cases.
In Denmark, The Danish Medicines Council started using QALY as a cost- effectiveness measure back in January 2021. What are the experiences to date using cost per QALY in the Danish Medicines Council?
This is a basic methodology course, where professionals working with market access for new, innovative medicines can get a deep dive into the use of health economic models as prioritisation tools.
Other course participants say
"Well-structured and relevant content. Seasoned lecturers who navigated the topic flawlessly regardless of the questions asked. An engaging format."
Esben Baes-Carlsen
"High professionalism and theory that translates into practice."
Pia Holmgaard, Market Access & HC Affairs Manager, Boehringer Ingelheim Danmark A/S
"It gives an excellent overview of health economic analysis models and examples."
Jeanett Jensen, Market Access Lead, Takeda Pharma A/S
Keywords
- Health economic models
- QALY and ICER
- Health economic analysis
- Uncertainty
Save information for later
Course leader & lecturers
- Christian Graves BeckCourse leaderNordic HTA Enabler
Roche A/S - Morten HedegaardCourse leaderAssociate Director, Nordic Value, HTA & HEOR
Bristol Myers Squibb Danmark
Watch the video
Is this course for you?
The course is especially relevant for Market Access Managers, Medical Affairs (Heads of, MSLs), Commercial (Business Unit Heads), and Product managers.
What you will learn
- What health economic analyses can be used for.
- Types of health economic models.
- What an ICER is.
- The concept of a QALY and how it is calculated.
- Managing uncertainty in health economic models.
What your company will get
- An employee who understands the rationale behind using health economic analyses.
- An employee who knows the most used types of health economic models.
- An employee who understands what an ICER is.
- An employee who knows what a QALY is and how it is calculated.
- An employee who knows how to manage uncertainty in health economic models.
Course calendar
- The rationale behind the use of health economic analyses in Denmark.
- Introduction to ICER, QALY, and costs.
- What are the experiences to date since launching QALY in the Danish Medicines Council?
- Introduction to the most used types of health economic models.
- How to manage uncertainty in the health economic models.
Registration
Registration deadline6 May 2025
Lersø Parkallé 101
2100 København Ø
Course information
Examination
There is no examination for this course.
This course is a part of a diploma
Our Diploma in Market Access provides you with in-depth knowledge of the Danish healthcare system and its funding models and stakeholders. Raise your skill level in areas such as public affairs, stakeholder management and health economics by attending the four courses
Read moreCourse leaders
Roche A/S
Bristol Myers Squibb Danmark
Lecturers
Bristol Myers Squibb Danmark
Roche A/S
You may also be interested in these courses
4 Nov 2025
•
•
Want to know more, or need help?
Contact Client Manager Ida Salicath at +45 39 15 09 46